1.  Montaser-Kouhsari, L; Zartab, H; Fanian, F; Noorian, N; Sadr, B; Nassiri-Kashani, M; Firooz, A  ,Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: A randomized, controlled trialvJ DERMATOL TREA ,JOURNAL OF ,Volume: 25,Issue: 4 : 337-341 , AUG 2014.


2.  Eslami G, Hajimohammadi B, Jafari AA, Mirzaei F, Gholamrezai M, Anvari H, Khamesipour A  ,Molecular identification of Leishmania tropica infections in patients with cutaneous leishmaniasis from an endemic central of Iran , TROP BIOMED, 2014 Dec;31(4):592-9.


3.  Mortazavi, H; Esmaili, N; Khezri, S; Khamesipour, A; Farahani, IV ,Daneshpazhooh, M; Rezaei, N, The Effect of Conventional Immunosuppressive Therapy on Cytokine Serum Levels in Pemphigus Vulgaris Patients ,IRAN J ALLERGY ASTHM, V:13 ,Issue: 3,: 174-183,: JUN 2014


4.  Aflatoonian, MR; Sharifi, I; Parizi, MH; Fekri, AR; Aflatoonian, B , Sharifi, M,; Khosravi, A; Khamesipour, A .,Sharifi, HA , Prospective Cohort Study of Cutaneous Leishmaniasis Risk and Opium Addiction in South Eastern Iran, PLOS ONE, V: 9 ,Issue: 2, FEB 20 2014


5.  Zargari, O ,Hejazi, S; Shahidi-Dadras, M ,Younespour, S; Robati, R ,Firooz, A  ; Toosi, P; Feldman, SR , ,Considerable variation among Iranian dermatologists in the dosing and monitoring of methotr exate for treating psoriasis, INT J DERMATOL, V: 53 ,Issue: 3, : 385-389 ,: MAR 2014


6.  Eskandari, F; Talesh, GA; Parooie, M; Jaafari, MR; Khamesipour, A ,Saberi, Z  ; Abbasi, A; Badiee, A, Immunoliposomes containing Soluble Leishmania Antigens (SLA) as a novel antigen delivery system in murine model of leishmaniasis,,EXP PARASITOL , V: 146 ,: 78-86 : NOV 2014


7.  Ghaffari-Hoseini, S. ,Haghjooy-Javanmard, S. Zarkesh, S.H.,Khamesipour, A. Rafiei, L., Karbalaie, K. Nilforoushzadeh, M.A. Baghaei, M. Hejazi, S.H.Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major , Journal of Isfahan Medical School, V: 31, Issue 269, 2014: 2326-2335


8.  Anjomruz, M; Oshaghi, MA; Pourfatollah, AA; Sedaghat, MM  ; Raeisi, A  ; Vatandoost, H] ; Khamesipour, A; Abai, MR ; Mohtarami, F ; Akbarzadeh, K , Preferential feeding success of laboratory reared Anopheles stephensi mosquitoes according to ABO blood group status , ACTA TROP, V: 140, 118-123, DEC 2014


9.  Anjomruz M, Oshaghi MA, Pourfatollah AA, Sedaghat MM, Raeisi A, Vatandoost H, Khamesipour A, Abai MR, Mohtarami F, Akbarzadeh K, Rafie F,Besharati M


10.  Preferential feeding success of laboratory reared Anopheles stephensi mosquitoes according to ABO bloodgroup status. Acta Trop. 2014 140:118-23, 2014


11.  Mortazavi H, Soori T, Khamesipour A, Khatami A, Vasheghani-Farahani An, Co-existence of cutaneous leishmaniasis with pleural effusion: a case report from Iran, Acta Med Iran, 2014;52(3):231-3.


12.  Kiani J, Sajedi F, Nasrollahi SA, Esna-Ashari F, A randomized clinical trial of efficacy and safety of the topical clonidine and capsaicin in the treatment of painful diabetic neuropathy, J Res Med Sci 2015;20:359-63.


13.   Mehryan, P; Zartab, H; Rajabi, A; Pazhoohi, N; Firooz, A   Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles , J COSMET DERMATOL V: 13 ,Issue: 1,: 72-78 : MAR 2014


14.  Nassiri-Kashani, M.  Khatami, A. Ghafari, M. Firooz, A. Dowlati, Y  ,Comparison of patch testing results between job related and non job related allergic contact dermatitis in Iran , Iranian Journal of Dermatology, V: 17, Issue 68, 2014: 49-53


15.  Hoseini, SG; Javanmard, SH; Hejazi, SH; Rafiei, L; Zarkesh, SH ; Karbalaii, K; Khamesipour, A,  Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major , J RES MED SCI V: 19,: S36-S40 , MAR 2014


16.  Davoudi, N; Khamesipour, A; Mahboudi, F; McMaster, WR  , A Dual Drug Sensitive L. major Induces Protection without Lesion in C57BL/6 Mice ,PLOS NEGLECT TROP V: 8,Issue: 5 , MAY 2014


17.  Hosseini R, Naderi F, Nasrollahi SA, Determination of phenylethyl alcohol by reversedphase high-performance liquid chromatography (RPHPLC) in Budesonide nasal spray, African Journal of Pure and Applied Chemistry, Vol.9(5), pp. 81-90 , May 2015


18.  Jabini R, Jaafari MR, Vahdati Hasani F, Ghazizadeh F, Khamesipour A, Karimi G  ,Effects of Combined Therapy with Silymarin and Glucantime on Leishmaniasis Induced by Leishmania major in BALB/c Mice , Drug Res (Stuttg), 2015 Mar;65(3):119-24


19.  Bakhshi, H; Borhani, N; Mohebali, M; Khamesipour, A; Abai, MR; Hajjaran, H  ; Tajedin, L; Rassi, Y; Akhavan, AA; Mohtarami, F ,Interleukin 4 (IL-4) gene promoter polymorphisms in Rhombomys opimus, the main reservoir of zoonotic cutaneous leishmaniasis , CYTOKINE, V: 65 ,Issue: 1 ,JAN 2014


20.  Hossein Mortazavi,1,2 Alireza Khatami,3 Zahra Seyedin,2 Iman Vasheghani Farahani,4 and Maryam Daneshpazhooh  ,Salivary Desmoglein Enzyme-Linked Immunosorbent Assay for Diagnosis of Pemphigus Vulgaris: A Noninvasive Alternative Test to Serum Assessment, Biomed Research International, Volume 2015 (2015)


21.  Soleimanifard, S; Arjmand, R; Saberi, S; Khamesipour, A; Kazemi, M  ; Salehi, M; Akbari, M; Hejazi, S ,P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER), IRAN J PARASITOL, V: 9 ,Issue: 3 ,: 423-428 , JUL-SEP 2014


22.  Khamesipour A, The need to teach vaccine safety to basic scientists and public health officials.Curr Drug Saf. 2015;10(1):76-9.


23.  Firooz A, Aghazadeh N, Rajabi Estarabadi A, Hejazi P. The effects of water exposure on biophysical properties of normal skin. Skin Res Technol. 2015 May;21(2):131-6


24.  Khamesipour A. Therapeutic vaccines for leishmaniasis. Expert Opin Biol Ther. 2014 Nov;14(11):1641-9.


25.  Ahmadi M, Fata A, Khamesipour A, Rakhshandeh H, Miramin Mohammadi A, Salehi G, Monavari H, The efficacy of hydro alcoholic extract of Seidlitzia rosmarinus on experimental zoonotic cutaneousleishmaniasis lesions in murine model , Avicenna J Phytomed. 2014 Nov;4(6):385-91.


26.  Kalat SA, Khamesipour A, Bavarsad N, Fallah M, Khashayarmanesh Z, Feizi E, Neghabi K, Abbasi A, Jaafari MR, Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion inBALB/c mice, Exp Parasitol. 2014 Aug;143:5-10.


27.  Khamesipour, A. Aflatoonian, M.R., Sharifi, I., Parizi, M.H., , Sharifi, H.A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern iran,  PLoS ONE , 2014, 9(2)


28.  Khamesipour, A,Anjomruz, M., Oshaghi, M.A., Pourfatollah, A.A.,  Rafie, F., Besharati, M. Preferential feeding success of laboratory reared Anopheles stephensi mosquitoes according to ABO blood group status, Acta Tropica,2014, 140, pp. 118-123


29.  Khamesipour, A, Mortazavi, H., Soori, T., ., Khatami, A., Vasheghani-Farahani, A. Co-existence of cutaneous leishmaniasis with pleural effusion: A case report from Iran Acta Medica Iranica ,2014 ,52 (3), pp. 231-233


30.  Khamesipour, A. Hoseini, S.G., Javanmard, S.H., Hejazi, S.H., Karbalaii, K. Comparison of immune regulatory factors in acute and chronic lesions of cutaneous leishmaniasis due to Leishmania major, Journal of Research in Medical Sciences,2014 ,19 (SPEC. ISSUE), pp. S36-S40


31.  Khamesipour, A, Ghaffari-Hoseini, S., Haghjooy-Javanmard, S., Zarkesh, S.H.,, Baghaei, M., Hejazi, S.H.  Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major  ,Journal of Isfahan Medical School 31, 2014 (269 SPEC.ISSUE), pp. 2326-2335


32.  Khamesipour, A. Moosavian Kalat, S.A., , Bavarsad, N., , Abbasi, A., Jaafari, M.R.  Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice. Experimental Parasitology , 2014 143 (1), pp. 5-10


33.  Khamesipour, A,Davoudi, N., ., Mahboudi, F., McMaster, W.R.A Dual Drug Sensitive L. major Induces Protection without Lesion in C57BL/6 Mice, 2014 PLoS Neglected Tropical Diseases 8 (5), e2785


34.  Bakhshi, H., Borhani, N., Mohebali, M., Mohtarami, F., Oshaghi, M.A. Interleukin 4 (IL-4) gene promoter polymorphisms in Rhombomys opimus, the main reservoir of zoonotic cutaneous leishmaniasis 2014,,Cytokine 65 (1), pp. 1-3


35.  Mortazavi, H., Esmaili, N., Khezri, S., , Daneshpazhooh, M., Rezaei, N.Document The effect of conventional immunosuppressive therapy on cytokine serum levels in pemphigus vulgaris patients  Iranian Journal of Allergy, Asthma and Immunology , 201413 (3), pp. 174-183


36.  Montaser-Kouhsari, L., Zartab, H., Fanian, F., Nassiri-Kashani, M., Firooz, A.Comparison of intradermal injection with iontophoresis of abobotulinum toxin A for the treatment of primary axillary hyperhidrosis: A randomized, controlled trial, 2014 ,Journal of Dermatological Treatment 25 (4), pp. 337-341


37.  Firooz, A., Aghazadeh, N., Rajabi Estarabadi, A., Hejazi, P. The effects of water exposure on biophysical properties of normal skin ,2014  ,Skin Research and Technology


38.  Zargari, O., Hejazi, S., Shahidi-Dadras, M., Toosi, P., Feldman, S.R., Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis, 2014 ,International Journal of Dermatology ,53 (3), pp. 385-389


39.  Mehryan, P., Zartab, H., Rajabi, A., Pazhoohi, N., Firooz, A.Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles,  Journal of Cosmetic Dermatology , 2014 13 (1), pp. 72-78


40.  Khatami, A., Nassiri-Kashani, M., Gorouhi, F., (...), Dowlati, Y., Firooz, A,.Allergic contact dermatitis to metal allergens in Iran  International Journal of Dermatology, 2013, 52 (12), pp. 1513-1518


41.  Mir Amin Mohammadi, A., Khamesipour, A., Khatami, A., , Behnia, M., Eskandari, S.E. Cutaneous leishmaniasis in suspected patients referred to the Center for Research and Training in Skin diseases and Leprosy, Tehran, Iran from 2008 to 2011 , 2013 ,Iranian Journal of Parasitology,8 (3), pp. 430-436


42.  Kochhar, S., Rath, B., Seeber, L.D., (...), Khamesipour, A., Ali, M. Introducing new vaccines in developing countries , Expert Review of Vaccines, 2013,12 (12), pp. 1465-1478


43.  Firouzmand, H., Badiee, A., Khamesipour, A., Abbasi, A., Jaafari, M.R.  Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA) ,2013,Acta Tropica,128 (3), pp. 528-535


44.  Bonhoeffer, J., Imoukhuede, E.B., Aldrovandi, G.,  Zaman, K., Heininger, U.  Template  protocol for clinical trials investigating vaccines-Focus on safety elements , Vaccine, 2013,31 (47), pp. 5602-5620


45.  Tolouei, S., Hejazi, S.H., Hasheminia, S.J.,  Khamesipour, A., Nilforoushzadeh, M.A. Study of   IL-12 agonists in macrophages from patients with healing and non-healing forms  of cutaneous   leishmaniasis ,2013, Journal of Isfahan Medical School ,31 (252), pp. 1435-1442  


46.  Tolouei, S.a, Hejazi, S.H.a  , Ghaedi, K.b, Khamesipour, A.c, Hasheminia, S.J.Scandinavian, TLR2 and TLR4 in Cutaneous Leishmaniasis Caused by Leishmania major  2013,Journal of Immunology Volume 78, Issue 5 478-484


47.  Kazemi-Rad, E.a, Mohebali, M.ab  , Erfan, M.B.K.a, Saffari, M.c, Raoofian, R.cd, Hajjaran, H.a, Hadighi, R.e, Khamesipour, A.f, Rezaie, S.a, Abedkhojasteh, H.a, Heidari, M. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach,  2013, Experimental Parasitology ,Volume 135, Issue 2, 344-349


48.  Mir Amin Mohammadi, A., Khamesipour, A., Khatami, A., Behnia, M., Eskandari, S.E. Cutaneous  leishmaniasis in suspected patients referred to the Center for Research and Training in Skin   diseases and Leprosy, Tehran, Iran from 2008 to 2011, Iranian Journal of Parasitology ,2013,8 (3), pp.  430-436


49.  Rezaei Riabi, T., Sharifi, I., Miramin Mohammadi, A., Khamesipour, A., Hakimi Parizi, M. 2013  Evaluation of a possible synergistic effect of meglumine antimoniate with paromomycin, miltefosine or allopurinol on in vitro susceptibility of Leishmania tropica resistant isolate,Iranian Journal of Parasitology,8 (3), pp. 396-401


50.  Kheirandish, F., Sharafi, A.C., Kazemi, B., (...), Tarahi, M.J., Khamesipour, A. First molecular   identification of Leishmania species in a new endemic area of cutaneous leishmaniasis in Lorestan, Iran 2013 Asian Pacific Journal of Tropical Medicine 6 (9), pp. 713-717


51.  Chavoshian O., Biari, N., Badiee, A., (...), Jalali, S.A., Jaafari, M.R. Sphingomyelin liposomes containing  soluble leishmania major antigens induced strong Th2 immune response in BALB/c mice 2013 ,Iranian Journal of Basic Medical Sciences ,16 (9), pp. 965-972


52.  Kazemi-Rad, E., Mohebali, M., Khadem-Erfan, M.B., (...), Raoofian, R., Heidari, M. Overexpression of  ubiquitin and amino acid permease genes in association with antimony resistance in Leishmania tropica field isolates ,2013 ,Korean Journal of Parasitology , 51 (4), pp. 413-419


53.  Khatami, A., Talaee, R., Rahshenas, M., (...), Dowlati, Y., Firooz, A.  Dressings Combined with Injection of Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis: A Randomized Controlled Clinical Trial ,2013, PLoS ONE,8 (6), e66123


54.  Kheirandish, F., Bandehpour, M., Davoudi, N., (...), Mohebali, M., Mahboudi, F.  Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct ,2013, Iranian Journal of Parasitology ,8 (2), pp. 190-196


55.  Barati, M., Mohebali, M., Alimohammadian, M.H., (...), Akhoundi, B., Zarei, Z. Canine visceral leishmaniasis: seroprevalence survey of asymptomatic dogs in an endemic area of northwestern Iran 2013 , Journal of Parasitic Diseases ,pp. 1-4


56.  Alvar, J., Croft, S.L., Kaye, P., (...), Sundar, S., Reed, S.G.  Case study for a vaccine against leishmaniasis ,2013, Vaccine ,31 (SUPPL2), pp. B244-B249


57.  Moin, A., Khamesipour, A., Hassan, Z.M., (...), Naghizadeh, M.-M., Ghazanfari, T.  Pro-inflammatory cytokines among individuals with skin findings long-term after sulfur mustard exposure: Sardasht-Iran Cohort Study,2013,,International Immunopharmacology ,17 (3), pp. 986-990


58.  Ghasemi, H., Mostafaie, A., Yaraee, R., (...), Ghassemi-Broumand, M., Ghazanfari, T.Association of serum immunoglobulins levels and eye injuries in sulfur mustard exposed: Sardasht-Iran Cohort Study ,2013,International Immunopharmacology ,17 (3), pp. 944-951


59.  Yarmohammadi, M.E., Hassan, Z.M., Mostafaie, A., (...), Naghizadeh, M.-M., Ghazanfari, T. Salivary levels of secretary IgA, C5a and alpha 1-antitrypsin in sulfur mustard exposed patients 20 years after the exposure, Sardasht-Iran Cohort Study (SICS) ,2013,International Immunopharmacology,17 (3), pp. 952-957


60.  Askari, N., Vaez-Mahdavi, M.-R., Moaiedmohseni, S., (...), Faghihzadeh, E., Ghazanfari, T.  Association of chemokines and prolactin with cherry angioma in a sulfur mustard exposed population - Sardasht-Iran cohort study, 2013,International Immunopharmacology ,17 (3), pp. 991-995


61.  Arjmand, R., Soleimanifard, S., Saberi, S., Khamesipour, A., Hejazi, S.H. Comparison of protein profile of killed and autoclaved leishmania major using polyacrylamide gel electrophoresis ,2013, Journal of Isfahan Medical School ,30 (221), pp. 2460-2466


62.  Badiee, A., Heravi Shargh, V., Khamesipour, A., Jaafari, M.R. Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends , 2013, Vaccine ,31 (5), pp. 735-7


63.  Keshavarz Valian, H., Nateghi Rostami, M., Tasbihi, M., Sarrafnejad, A., Khamesipour, A. CCR7+ central and CCR7 effector memory CD4+ T cells in human cutaneous leishmaniasis ,2013, Journal of Clinical Immunology ,3 (1), pp. 220-234


64.  Arjmand, R., Soleimanifard, S., Saberi, S., Khamesipour, A., Hejazi, S.H.  Comparison of protein profile of killed and autoclaved leishmania major using polyacrylamide gel electrophoresis ,2013, Journal of Isfahan Medical School ,30 (211), pp. 2460-2466


65.  Badiee, A., Khamesipour, A., Samiei, A., Mahboudi, F., Jaafari, M.R.  The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen. 2012,Experimental parasitology ,132 (4), pp. 403-409


66.  Rath, B., Ali, M., Elemuwa, C., Chitwood, I., Kochhar, S. Prioritizing polio ,2012, Expert Review of Vaccines ,11 (12), pp. 1389-1392


67.  Khamesipour, A., Jafari Shakib, R.  One swallow doesn't bring spring. Response to letter to editor. 2012 , Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis ,47 (3), pp. 371


68.  Alavizadeh, S.H., Badiee, A., Khamesipour, A., Abbasi, A., Jaafari, M.R.The role of liposome-protamine-DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB/c mice  2012,Experimental Parasitology ,132 (3), pp. 313-319


69.  Latifynia, A., Khamesipour, A., Bokaie, S., Khansari, N.  Antioxidants and proinflamatory cytokines in the sera of patients with cutaneous leishmaniasis ,2012, Iranian Journal of Immunology ,9 (3), pp. 208-214


70.  Eskandari, S.E., Azimzadeh, A., Bahar, B., Khamesipour, A., Mohamadi, M.  Efficacy of microwave and infrared radiation in the treatment of the skin lesions caused by leishmania major in an animal model , 2012, Iranian Journal of Public Health ,41 (8), pp. 80-83


71.  Hejazi, S.H., Hoseini, S.G., Javanmard, S.H., Zarkesh, S.H., Khamesipour, A.  Interleukin-10 and transforming growth factor-β in early and late lesions of patients with Leishmania major induced cutaneous Leishmaniasis , 2012, Iranian Journal of Parasitology ,7 (3), pp. 16-23


72.  Bavarsad, N., Fazly Bazzaz, B.S., Khamesipour, A., Jaafari, M.R.  Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice 2012 , Acta Tropica ,124 (1), pp. 33-41


73.  Golali, E., Jaafari, M.R., Khamesipour, A., Saberi, Z., Badiee, A.Comparison of in vivo adjuvanticity of liposomal PO CpG odn with liposomal PS CpG ODN: Soluble leishmania antigens as a model 2012 ,Iranian Journal of Basic Medical Sciences ,15 (5), pp. 1032-1045


74.  Khamesipour, A., Nateghi Rostami, M., Tasbihi, M., Eskandari, S.E., Keshavarz Valian, H.  Phenotyping of circulating CD8 + T cell subsets in human cutaneous leishmaniasis , 2012 ,Microbes and Infection,14 (9), pp. 702-711


75.  Heravi Shargh, V., Jaafari, M.R., Khamesipour, A.,Abbasi, A., Badiee, A.  Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis ,2012,Parasitology Research ,111 (1), pp. 105-114


76.  Hejazi, S.H., Hoseini, S.G., Javanmard, S.H., Zarkesh, S.H., Khamesipour, A.  Interleukin-10 and transforming growth factor-β in early and late lesions of patients with Leishmania major induced cutaneous leishmaniasis , 2012,Iranian Journal of Parasitology ,7 (2), pp. 53-60


77.  Shargh, V.H., Jaafari, M.R., Khamesipour, A., Abbasi, A., Badiee, A.  Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis ,2012,Vaccine ,30 (26), pp. 3957-3964


78.  Rath, B., Ali, M., Codarini, G.,  Varughese, S., Kochhar, S.  Promoting evidence-based vaccine safety research and communication-The Vienna vaccine safety initiative , 2012,Journal of Tropical Pediatrics ,58 (3), fms022, pp. 167-169


79.  Tolouei, S., Ghaedi, K., Khamesipour, A.,Narimani, M., Hejazi, S.H.   IL-23 and IL-27 levels in macrophages collected from peripheral blood of patients with healing vs non-healing form of cutaneous leishmaniasis , 2012, 7 (1), pp. 18-25


80.  Muehlhans, S., Richard, G., Ali, M., , Vuitton, D., Rath, B. Safety reporting in developing country vaccine clinical trials-A systematic review  2012, Vaccine ,30 (22), pp. 3255-3265


81.  Pardakhty, A., Shakibaie, M., Daneshvar, H., Mohammadi-Khorsand, T., Forootanfar, H. Preparation and evaluation of niosomes containing autoclaved Leishmania major: A preliminary study,2012, Microencapsulation ,29 (3), pp. 219-224


82.  Hoseini, S.G., Javanmard, S.H., Zarkesh, S.H.,  Baghaei, M., Hejazi, S.H.  Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to leishmania major,2012,Journal of Research in Medical Sciences,17 (6), pp. 513-518


83.  Khamesipour, A.a  , Abbasi, A.b, Firooz, A.a, Amin Mohammadi, A.M.a, Eskandari, S.E.a, Jaafari, M.R. Treatment of cutaneous lesion of 20 years' duration caused by leishmanization , 2012 ,Indian Journal of Dermatology, 57, 2, :123-125


84.  Shokri, A., Sharifi, I., Khamesipour, A., Parizi, M.H., Barati, M. The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate,2012,Parasitology Research,110 (3), pp. 1113-1117


85.  Akhavan, A.A., Ghods, R., Jeddi-Tehrani, M., Khamesipour, A., Mahmoudi, A.R. Production and purification of anti-Rhombomys opimus immunoglobulins , 2011, Iranian Journal of Arthropod-Borne Diseases,5 (2), pp. 69-76


86.  Hamidizadeh, N., Barikbin, B., Yousefi, M.,  Younespour, S., Sadeghitehrani, H.  The effect of different concentrations of topical podophyllin on cutaneous leishmaniasis,2011, Iranian Journal of Dermatology ,14 (56), pp. 48-51


87.  Sharifi, I., Nakhaei, N., Aflatoonian, M.R.,  Khamesipour, A., Nadim, A. Cutaneous leishmaniasis in bam: A comparative evaluation of pre- and post- earthquake years (1999-2008),2011, Iranian Journal of Public Health,40 (2), pp. 49-56


88.  Tafaghodi, M., Eskandari, M., Khamesipour, A., Jaafari, M.R. Alginate microspheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN induced partial protection and enhanced immune response against murine model of leishmaniasis ,2011, Experimental Parasitology,129 (2), pp. 107-114


89.  Khamesipour, A., Amiri, Z.M., Kafiabad, S.A., , Esteghamati, A.-R., Shakib, R.J. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran,2011Transfusion and Apheresis Science,45 (2), pp. 195-197


90.  Tolouei, S., Hasheminia, S.J., Narimani, M., , Shatalebi, M.A., Hejazi, S.H.  Leishmanicidal activity of films containing paromomycin and gentamicin sulfate both in vitro and in vivo, 2011, Iranian Journal of Parasitology ,6 (3), pp. 60-65


91.  Eslami, G., Frikha, F., Salehi, R., , Hejazi, H., Nilforoushzadeh, M.A.  Cloning, expression and dynamic simulation of TRYP6 from Leishmania major (MRHO/IR/75/ER) Eslami, G., Frikha, F., Salehi, R., Hejazi, H., Nilforoushzadeh, M.A. 2011,Molecular Biology Reports ,38 (6), pp. 3765-3776


92.  Pazoki-Toroudi, H.abc  , Nilforoushzadeh, M.A.ad, Ajami, M.e, Jaffary, F.d, Aboutaleb, N.b, Nassiri-Kashani, M.f, Firooz, A. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris  ,  2011, Cutaneous and Ocular Toxicology Volume 30, Issue 4, Pages 286-291


93.  Saghravanian, N.a, Ghazvini, K.b, Babakoohi, S.c, Firooz, A.c, Mohtasham, N. Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma,  2011, Acta Odontologica Scandinavica, 69, 6, 406-409


94.  Mohtasham, N.a, Babakoohi, S.bc  , Montaser-Kouhsari, L.bc, Memar, B.d, Salehinejad, J.a, Rahpeyma, A.e, Khageh-Ahmady, S.a, Marouzi, P.f, Firooz, A.b, Pazoki-Toroudi, H.b, Anvari, K. The expression of heat shock proteins 27 and 105 in squamous cell carcinoma of the tongue and relationship with clinicopathological index,  2011 ,Medicina Oral, Patologia Oral y Cirugia Bucal , 16 6, September, Pages 730-735


96.  Javanbakht, M.H.a, Keshavarz, S.A.a, Djalali, M.a, Siassi, F.a, Eshraghian, M.R.b, Firooz, A.c, Seirafi, H.d, Ehsani, A.H.d, Chamari, M.a, Mirshafiey, A, Randomized controlled trial using vitamins e and D supplementation in atopic dermatitis  , 2011,Journal of Dermatological Treatment,22,  3, 144-150


97.  Khatami, A., Firooz, A.  , Nassiri-Kashani, M., Dowlati, Y. Few comments on the treatment of Old World cutaneous leishmaniasis  , 2011, International Journal of Dermatology, 50, 6, 754-754


98.  Firooz, A.a  , Sadr, B.a, Davoudi, S.M.b, Nassiri-Kashani, M.a, Panahi, Y.c, Dowlati, Y Long-term skin damage due to chemical weapon exposure, 2011. Cutaneous and Ocular Toxicology , 30, 1 , 64-68


 


99.  Firooz, A.  , Nassiri-Kashani, M., Khatami, A., Gorouhi, F., Babakoohi, S., Montaser-Kouhsari, L., Davari, P., Dowlati, Y. Fragrance contact allergy in Iran , 2010, ,Journal of the European Academy of Dermatology and Venereology, 24, 12, 1437-1441


100.  Mohtasham, N.a, Babakoohi, S.bc, Nejad, J.S.a, Montaser-Kouhsari, L.bc, Shakeri, M.T.d, Shojaee, S.e, Sistani, N.S.f  , Firooz, A, Mast cell density and angiogenesis in oral dysplastic epithelium and low- and high-grade oral squamous cell carcinoma  2010, Acta Odontologica Scandinavica, 68, 5, 300-304


101.  Pazoki-Toroudi, H.a, Ajami, M.b, Babakoohi, S.a, Khaki, L.c, Habibey, R.d, Akhiani, M.e, Seirafi, H.e, Firooz, A, Effects of diphencyprone on expression of Bcl-2 protein in patients with Alopecia areata  , 2010.Immunopharmacology and Immunotoxicology 32, 3, 422-425


102.  Kashani, M.N.a  , Sadr, B.a, Nilforoushzadeh, M.A.a, Arasteh, M.b, Babakoohi, S.a, Firooz, A. Treatment of acute cutaneous leishmaniasis with intralesional injection of meglumine antimoniate: Comparison of conventional technique with mesotherapy gun  , 2010,International Journal of Dermatology, 49, 9,  1034-103


103.  Pazoki-Toroudi, H.ab  , Nassiri-Kashani, M.a, Tabatabaie, H.a, Ajami, M.c, Habibey, R.d, Shizarpour, M.a, Babakoohi, S.a, Rahshenas, M.a, Firooz, A. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris,2010,Journal of Dermatological Treatment, 21, 3, 212-216


104.  Sedighipour, L.a, Firooz, A.b, Pourpak, Z.a  , Ghaeini, I.a, Ghobari, B.c, Kazemnejad, A.d, Afrooz, G.A.c  ,Behavioral characteristics in 18- to 36-month-old toddlers with atopic dermatitis compared with healthy children  2010, Pediatric Dermatology, 27, 3,  314-315


105.  Davoudi, S.M.a, Sadr, B.b  , Hayatbakhsh, M.R.c, Keshavarz, S.a, Shohrati, M.a, Naghizadeh, M.M.a, Babakoohi, S.b, Rashighi-Firouzabadi, M.b, Firooz, A. Comparative study of skin sebum and elasticity level in patients with sulfur mustard-induced dermatitis and healthy controls  , 2010, Skin Research and Technology,  16, 2, , 237-242


106.  Javanbakht, M.H.a, Keshavarz, S.A.a  , Mirshafiey, A.b, Djalali, M.a, Siassi, F.a, Eshraghian, M.R.c, Firooz, A.R.d, Seirafi, H.e, Ehsani, A.H.e, Chamari, M. The effects of vitamins E and D supplementation on erythrocyte superoxide dismutase and catalase in atopic dermatitis  , 2010,Iranian Journal of Public Health, 39 1, 57-63


107.  Maziar, A.a, Farsi, N.a, Mandegarfard, M.b, Babakoohi, S.b, Gorouhi, F.b, Dowlati, Y.b, Firooz, A. Unwanted facial hair removal with laser treatment improves quality of life of patients,, 2010,  Journal of Cosmetic and Laser Therapy,12 1, 7-9


108.  107.     Costa, C.H.N.a  , Peters, N.C.b  , Maruyama, S.R.c  , de Brito Jr., E.C.a  , Santos, I.K.F.M.cd  , Ali, N.e  Brodskyn, C.f  , Campos-Neto, A.g  , Carvalho, E.M.h  , Chang, K.P.i  , Fernandes, A.P.j  , Fujiwara, R.k  Gazzinelli, R.lm  ,Walden, P.ac  , Werneck, G, Vaccines for the leishmaniases: Proposals for a  research Agenda  ,  2011,PLoS Neglected Tropical Diseases. 5,  3,  e943


109.  Nateghi Rostami, M., Keshavarz, H., Edalat, R., Sarrafnejad, A., Shahrestani, T., Mahboudi, F., Khamesipour, A. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis, , 2010, (PLoS neglected tropical diseases, 4, 10, e845


110.  Tafaghodi, M.a, Eskandari, M.a, Kharazizadeh, M.a, Khamesipour, A.b, Jaafari, M.R, Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins , 2010, Tropical Biomedicine, 27, 3,  639-650


111.  Akhavan, A.A.a, Mirhendi, H.b, Khamesipour, A.c, Alimohammadian, M.H.d, Rassi, Y.a, Bates, P.e, Kamhawi, S.f, Valenzuela, J.G.f, Arandian, M.H.g, Abdoli, H.g, Jalali-zand, N.g, Jafari, R.g, Shareghi, N.g, Ghanei, M.g, Yaghoobi-Ershadi, M.R Leishmania species: Detection and identification by nested PCR assay from skin samples of rodent reservoirs  , 2010,Experimental Parasitology, 126, 4,  552-556


112.  Rostami, M.N.ab, Keshavarz, H.a, Edalat, R.c, Sarrafnejad, A.d, Shahrestani, T.d, Mahboudi, F.d, Khamesipour, A, CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis, 2010,PLoS Neglected Tropical Diseases,4, 10, , e845


113.  Akhavan, A.A.a, Yaghoobi-Ershadi, M.R.a  , Khamesipour, A.b, Mirhendi, H.c, Alimohammadian, M.H.d, Rassi, Y.a, Arandian, M.H.e, Jafari, R.e, Abdoli, H.e, Shareghi, N.e, Ghanei, M.e, Jalali-Zand, N.e, Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran  , 2010,Bulletin de la Societe de Pathologie Exotique, 103,  2,  84-89


114.  Sharifi, I.a  , Fekri, A.R.a, Aflatoonian, M.R.a, Khamesipour, A.b, Mahboudi, F.c, Dowlati, Y.b, Nadim, A.d, Modabber, F. Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006, 2010 ,International Journal of Dermatology, 49, 5, , 557-561


115.  Rostami, M.N., Valian, H.K., Eskandari, S.E., Mohammadi, A.M., Shahrestani, S.T., Sarraf-Nejad, A., Khamesipour, A. Erratum: Differential in vitro CD4+/CD8+ T-cell response to live vs. killed Leishmania major (Parasite Immunology (2010) 32 (101-110) -3024. Parasite Immunology, 32, 5, e 388


116.  Nateghi Rostami, M.a, Keshavarz, H.a, Khamesipour, A, Immune response of BALB/c mice against an experimental vaccine of alum precipitated autoclaved Leishmania major (Alum-ALM) mixed with BCG or Mycobacterium vaccae  , 2010,Tropical Biomedicine, 27, 1, 89-102


117.  Hejazi, H.a, Tasbihi, M.a, Jaafari, M.R.b, Badiee, A.b, Pestechian, N.a, Javadi, A.c, Khamesipour, The role of liposomal CpG ODN on the course of L. major infection in BALB/C mice,, 2010,  Iranian Journal of Parasitology, 5, 1, 47-54


118.  Akhavan, A.A.a, Yaghoobi-Ershadi, M.R.a, Mirhendi, H.b, Alimohammadian, M.H.c, Rassi, Y.a, Shareghi, N.d, Jafari, R.d, Arandian, M.H.d, Abdoli, H.d, Ghanei, M.d, Jalali-Zand, N.d, Khamesipour, A. Molecular epizootiology of rodent leishmaniasis in a hyperendemic area of Iran  , , 2010,Iranian Journal of Public Health, 39, 1,  1-7


 


119.  Nateghi Rostami, M.a, Keshavarz Valian, H.a, Eskandari, S.E.b, Miramin Mohammadi, A.b, Shahrestani, S.T.c, Sarraf-Nejad, A.c, Khamesipour, A, Differential in vitro CD4+/CD8+ T-cell response to live vs. killed Leishmania major  , 2010, Parasite Immunology, 32, 2, , 101-110


120.  Hejazi, S.H.a, Zia- Jahromi, N.b, Bandehpour, M.c, Eslami, G.a, Salehi, R.d, Khamesipour, A.e, Kazemi, B. Gene cloning of Iranian Leishmania major mannose-1-phosphate guanyltransferase  . 2009, Iranian Journal of Parasitology Volume 4, Issue 3, , Pages 1-9


121.  Monot, M.a, Honoré, N.a, Garnier, T.a, Zidane, N.a, Sherafi, D.a, Paniz-Mondolfi, A.b, Matsuoka, M.c, Taylor, G.M.d, Donoghue, H.D.d, Bouwman, A.e, Mays, S.f, Watson, C.g, Lockwood, D.g, Khamesipour, A.h, Dowlati, Y.h, Jianping, S.i, Rea, T.H.j, (...), Brennan, P.J.o, Cole, S.T. Comparative genomic and phylogeographic analysis of Mycobacterium leprae , 2009, Nature Genetics,Volume 41, Issue 12, , Pages 1282-1289


122.  Hejazi, S.H.a, Zia-Jahromi, N.b, Bandehpour, M.c, Eslami, G.a, Salehi, R.d, Khamesipour, A.e, Kazemi,Cloning of Iranian Leishmania major mannose-1-phosphate guanyltransferase gene, 2009, African Journal of Biotechnology,Volume 8, Issue 23, 1, Pages 6495-6498


123.  Fata, A.a  , Khamesipour, A.b, Mohajery, M.c, Hosseininejad, Z.a, Afzalaghaei, M.a, Berenji, F.a, Ganjbakhsh, M.a, Akhavan, A.A.d, Eskandari, E.b, Amin-Mohammadi, A., Whatman paper (FTA cards) for storing and transferring Leishmania DNA for PCR examination  , , 2009,Iranian Journal of Parasitology,Volume 4, Issue 4, Pages 37-42


124.  Noazin, S.a, Modabber, F.bch, Khamesipour, A.c, Smith, P.G.d, Moulton, L.H.e, Nasseri, K.f, Sharifi, I.g, Khalil, E.A.G.h, Bernal, I.D.V.i, Antunes, C.M.F.j, Kieny, M.P.a  , Tanner, M. First generation leishmaniasis vaccines: A review of field efficacy trials  2008 Vaccine, Volume 26, Issue 52, 9: 6759-6767


125.  Nateghi Rostami, M.a, Khamesipour, A.b, Eskandari, S.E.b, Miramin Mohammadi, A.b, Sarraf Nejad, A.c, Keshavarz, H.a Flow cytometric analysis of leishmania reactive CD4+/CD8+lymphocyte proliferation in cutaneous leishmaniasis  2008, Iranian Journal of Parasitology, Volume 3, Issue 4, , Pages 9-18


126.  Lieke, T.af  , Nylén, S.a, Eidsmo, L.a, McMaster, W.R.cd, Mohammadi, A.M.e, Khamesipour, A.e, Berg, L.ab, Akuffo, H. Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation,  2008 ,Clinical and Experimental Immunology,Volume 153, Issue 2, :221-230


127.  Jafari-Shakib, R.ah, Ajdary, S.e, Amiri, Z.M.g, Mohammadi, A.M.b, Nourijelyani, K.c, Mortazavi, H.d, Shokrgozar, M.A.f, Nikbin, B.a, Khamesipour, A. CD26 expression on CD4+ T cells in patients with cutaneous leishmaniasis  , 2008,Clinical and Experimental Immunology Volume 153, Issue 1, 31-36


128.  Keshavarz Valian, H.a, Khoshabe Abdollah Kenedy, L.a, Nateghi Rostami, M.a, Miramin Mohammadi, A.b, Khamesipour, A., Role of Mycobacterium vaccae in the protection induced by first generation Leishmania vaccine against murine model of leishmaniasis ,  2008,Parasitology Research, 103, 1, , 21-28


129.  Badiee, A.ab, Jaafari, M.R.a, Samiei, A.a, Soroush, D.a, Khamesipour, A. Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice,  2008, Clinical and Vaccine Immunology, Volume 15, Issue 4, April  ,668-674


130.  Nilforoushzadeh, M.A.a, Jaffary, F.a, Ansari, N.a, Siadat, A.H.a  , Nilforoushan, Z.a, Firouz, A., A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis,  2008, Journal of Vector Borne Diseases Volume 45, Issue 4, 287-291


131.  Davoudi, S.M.a, Behnia, F.b, Gorouhi, F.b, Keshavarz, S.a, Kashani, M.N.b, Firoozabadi, M.R.b, Firooz, A. Comparison of long-pulsed alexandrite and Nd:YAG lasers, individually and in combination, for leg hair reduction: An assessor-blinded, randomized trial with 18 months of follow-up, 2008, Archives of Dermatology Volume 144, Issue 10, October, Pages 1323-1327


132.  Firooz, A.ad  , Ghandi, N.b, Hallaji, Z.b, Chams-Davatchi, C.b, Valikhani, M.b, Davari, M.K.


133.  132.   Archives of Dermatology, Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris   2008, Volume 144, Issue 9, , Pages 1143-1147


134.  Khatami, A.  , Firooz, A., Gorouhi, F., Khamesiour, A., Dowlati, Y., Cutaneous leishmaniasis The Lancet Infectious Diseases, Volume 8, Issue 8, 2008, 458


135.  Davari, P.a, Gorouhi, F.a, Jafarian, S.a, Dowlati, Y.a, Firooz, A. A randomized investigator-blind trial of different passes of microdermabrasion therapy and their effects on skin biophysical characteristics,  2008, International Journal of Dermatology ,Volume 47, Issue 5, May, Pages 508-513


136.  Jamshidi, F.a, Bouzari, N.c, Seirafi, H.a, Farnaghi, F.a, Firooz, A, The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran,  2008 ,Archives of Iranian Medicine Volume 11, Issue 2, , :162-165


137.  Firooz, A.  , Kashani, M.N, Diagnostic criteria for atopic dermatitis, 2008, Journal of the European Academy of Dermatology and Venereology, 22,  1, :130


138.  Khatami, A.  , Ghorbani, Z., Gorouhi, F., Davari, P., Firooz, A. Angiokeratoma and epidermal nevus [20]  , 2008, European Journal of Dermatology, Volume 18, Issue 1, , Pages 100-101


139.  Rashighi Firoozabadi M, Firooz A, Gorouhi F, Dowlati Y. Iran's contribution to dermatology world literature. International Journal of Dermatology. 2007;46:659-60


140.  Modabber F, Buffet PA, Torreele E, Milon G, Croft SL. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Kinetoplastid Biology and Disease 2007;6:3


141.  Jaffari F, Musini V, Nilforoushzadeh MA, Bassett K. Systematic review of imiquimod for the treatment of external genital wart. International Journal of Pharmacology. 2007;3:1-10.


142.  Badiee A, Jaffari MR, Khamesipour A. Leishmania major : Immune response in Balb/C  mice immunized with stress-inducible protein 1 encapsulated in liposomes. Experimental Parasitology. 2007;115:127-34.


143.  Karimzadegan-nia M, Mir-Amin-Mohammadi A, Bouzari N, Firooz A. Comparison of direct smear, culture and histology for the diagnosis of onychomycosis. Australasian Journal of Dermatology 2007;48: 18-21.


144.  Samadi Z, Gorouhi F, Davari P, Firooz A. Think globally, act locally: Expert opinions from Asia on the diagnosis and treatment of pemphigus vulgaris. Indian Journal of Medical Sciences. 2007;61:144-151.


145.  Firooz A, Farsi N, Rashighi Firoozabadi M, Gorouhi F. Pigmented Bowen's disease of the finger mimicking malignant melanoma. Archives of Iranian Medicine. 2007;10:255-57.


146.  Firooz A, Gorouhi F, Davari P, Hekmat S, Atarod M, Rashighi Firoozabadi M, Solhpour A. Comparison of hydration, sebum and pH values in clinically normal skin of patients with atopic dermatitis and healthy controls. Clinical & Experimental Dermatology. 2007;32:321-22.


147.  Seirafi H, Farnaghi F, Firooz A, Vasheghani-Farhani A, Alirezaie N, Dowlati Y. Pimecrolimus cream in repigmentation of vitiligo. Dermatology 2007;214:253-59.


148.  Ghasemi A, Gorouhi F, Rashighi-Firoozabadi M, Jafarian S, Firooz A. Striae gravidarum: Associated factors. Journal of European Academy of Dermatology and Venereology. 2007;21:743-46.


149.  Firooz A, Amin-Nejad R, Bouzari N, Nafar M, Firoozan A, Mahdavi-Mazdeh M. Sun protection in Iranian kidney transplant recipients: Knowledge, attitude, and practice. Journal of European Academy of Dermatology and Venereology. 2007;21:754-57.


150.  Firooz A, Nassiri-Kashani M, Sarhangnejad R, etal. Frequency of false positive responses in patients with multiple positive reactions in patch test. Iranian J Dermatol 2007; 10 (1): 4.


151.  Sohrabi Y, Jaafari M, Badiee A, etal. Evaluation of immune response against autoclaved Leishmania major incorporated into positively charged liposomes in Balb/c mice. Iranian J Dermatol 2007; 10 (1): 7.


152.  Moin A, Dowlati Y. The frequency of skin diseases among Hajj pilgrims in skin clinic of Iran in Saudi Arabia, 1993 and 1999. Iranian J Dermatol 2007; 9(4): 55- 6.


 


153.  Davoudi SM, Behnia F, Gorouhi F, et al. Laser – assisted hair removal: comparison of long- pulsed alexandrite and long- pulsed Nd: YAG lasers, individually and in combination. Iranian J Dermatol 2007; 9(4): 50- 2.


154.  Samadi Z, Gorouhi F, Davari P, Firooz A. Opinion of Experts from Asia on the diagnosis and treatment of pemphigus vulgaris. Iranian J Dermatol 2007; 9(4): 54- 5.


155.  Sadeghian G, Nilfroushzadeh MA. Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis.  International Journal of Dermatology. 2006;45: 819-21.


156.  Nilfroushzadeh MA, Jafari F, Reiszadeh MR. Comparative effect of topical trichloroacetic acid and intralesional meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. International Journal of Pharmacology 2006;2:633-36.


157.  Nylen S, Khamesipour A, Mohammadi A, et al. Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited. Vaccine 2006; 24 (47-48): 6944-6954.


 


158.  Nateghi Rostami M, Eskandari E, Garoosi Z, Mohajer N, Rezaian M, Keshavarz H. Serological study of Toxoplasma gondii infection using IFA method in renal transplant recipients. Iranian Journal Parasitolology 2006;1:31-38.


159.  Davoudi SM, Rashighi Firoozabadi M, Gorouhi F, Karimi Zarchi AA, Nasiri Kashani M, Dowlati Y, Firooz A. Patch testing in Iranian patients: A ten-year experience. Indian Journal of Dermatology. 2006;51:250-54.


160.  Bouzari N, Firooz A. Continuous education for renal transplant recipients. Dermatology 2006;212:399.


161.  Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo : Comparison of  male and female muslim patients in Iran. Gender Medicine 2006 ;3 :124-30.


162.  Firooz A, Solhpour AR, Gorouhi F, Daneshpazhooh M, Balighi K, Farsinejad K, Rashighi-Firoozabadi M, Dowlati Y. Pimecrolimus cream 1% vs. hydrocortisone acetate cream 1% in the treatment of facial seborrheic dermatitis: A randomized, investigator blind, clinical trial. Archives of Dermatology 2006 ;142 :1066-67.


163.  Firooz A. Multidrug therapy regimen for leprosy. Journal of American Academy of Dermatology. 2006;55:1115.


164.  Firooz A, Khamesipour A, Ghoorchi MH, Nassiri-Kashani M, Eskandari SE, Khatami A, Hooshmand B, Gorouhi F, Rashighi-Firoozabadi M, Dowlati Y. Imiquimod in combination with meglumine antimoniate for acute cutaneous leishmaniasis: A randomized assessor-blind controlled trial. Archives of Dermatology. 2006;142:1575-79.


165.  Firooz A, Khatami A. Itraconazole in the treatment of cutaneous leishmaniasis. International Journal of Dermatology. 2006;45:1446-47.


 


166.  Hadighi R, Mohebali M, Boucher P, Hajjaran H, Khamesipour A, Ouellette M. Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug resistant Leishmania tropica parasites. PLoS Medicine 2006;3:e162.


167.  Rassi A, Khatami A. Unilateral non- pigmenting fixed drug eruption associated with cotrimoxazole. Dermatology online Journal 2006;12:6.


168.  Khamesipour A, Rafati S, Davoudi N, et al. Leishmaniasis vaccine candidates for development: A global overview. Indian Journal Of Medical Research 2006; 123:423-38.


169.  Jaafari MR, Ghafarian A, Farrokh-Gisour A, et al. Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice. Vaccine 2006; 24: 5708-17.


170.  Bouzari N, Firooz AR. Lasers may induce terminal hair growth. Dermatologic Surgery 2006;32: 460.


171.  Ghazanfari T, Hassan Zm, Khamesipour A . Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium Sativum) treatment. Journal Of Ethnopharmacology. 2006;103:333-37.


172.  Sohrabi Y, Jaafari MR, Khamesipour A. Immune response evaluation against autoclaved Leishmania major encapsulated in liposome with different Tm in murine model. IJBMS 2006; 9(1): 58.


173.  Badiee A, Jaafari MR, Samiei A, et al. Immune response evaluation against leishmaniasis using liposomes containing rLm STI1 in murine model. IJBMS 2006; 8(4): 282.


174.  Rasi A, Tajziehchi L, Khatami A. Porokeratotic eccrine ostial and dermal duct nevus with sensory polyneuropathy and hyperthyroidism: report a case. Iranian J Dermatol 2006; 9(3): suppl 3: 50- 2.


175.  Nassiri- Kashani M, Mortazavi H, Amini S. Frequency of contact sensitivity in patients with contact or atopic dermatitis with patch test. Iranian J Dermatol 2006; 9(3): 41- 2


176.  Pourpak Z, Firooz A, Sedighipour L, et al. Behavioral characteristics in 3- 12 month- old infants with atopic dermatitis: A case control study. Iranian J Dermatol 2006; 9(3): 36- 7


177.  Nilforoushzadeh MA, Moradi S, Derakhshan R, et al. Efficacy of combination of topical honey with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis. Iranian J Dermatol 2006; 9(3): 34- 5.


178.  Jaffari F, Moradi S, Nilforoushzadeh MA, et al. The efficacy of topical treatment with concentrated boiled extract and hydroalcoholic extract of Cassia fistula in comparison with intralesional injection of glucantime in the treatment of acute leishmaniasis. Iranian J Dermatol 2006; 9(3): 32- 3.


179.  Hallaji Z, Chams – Davatchi C, Valikhani M, et al. The relation between thiopurine methyl transferase activity and efficacy and side effects of azathioprine in patients with pemphigus vulgaris. Iranian J Dermatol 2006; 9(3): 31- 2.


180.  Kouhkan A, Pourpak Z, Safaralizadeh R, et al. Serum and whole blood selenium in children with atopic dermatitis: a case control study. Iranian J Dermatol 2006; 9(2): 22- 3.


181.  Derakhshani F, Firooz A, Madani A, Mortazavi H. Frequency of UTI in children with atopic dermatitis in comparison with control group. Iranian J Dermatol 2006; 9 (2): 199.


182.  Tabatabai SH. A review on sunscreens and their efficacy in the prevention of skin cancers and melasma. Part 1. Iranian J Dermatol 2006; 9(1): 12- 3.


183.  Nilfroushzadeh MA, Sadeghian G, Jafari F, et al. Patch test results in patients with clinical diagnoses of contact and / or atopic dermatitis in Isfahan. Iranian J Dermatol 2006; 9(1): 5- 6.


184.  Sadeghian G, Nilfroushzadeh MA. The effect of combination therapy with systemic meglumine antimoniate (Glucantime) and pentoxifylline in the treatment of cutaneous leishmaniasis. Iranian J Dermatol 2006; 9(1): 2- 3.


185.  Naderi N, Mahdavi Mazdeh M, Firooz A, Heydari Seraj M. Prevalence of cutaneous manifestation in end stage renal disease patients under hemodialysis in Imam Khomeini hospital, Tehran in 2003. Iranian J Dermatol 2006; 8(6): 93- 4.


186.  Sadeghian G, Nilfroushzadeh MA, Amini M. comparison of insulin resistance  in obese women with and without a acanthosis nigricans. Iranian J Dermatol 2006; 8(6): 88- 9.


187.  Nilfroushzadeh MA, Ansarin N, Derakhshan R. Frequency of resistance to systemically administered meglomine antimoniate (Glucantime) in patients with acute cutaneous leishmaniasis: A cross – sectional study. Iranian J Dermatol 2006; 8(6): 86- 7.


188.  Nateghi Rostami M, Keshavarz H, Miramin Mohammadi A, Khamesipour A. Evaluation of protectivity and immunogenicity of alum precipitated autoclaved Leishmania major vaccine mixed with Mycobacterium vaccae in the murine model of leishmaniasis. Iranian J Dermatol 2006; 8(6): 75 - 7.


189.  Nilforoushzadeh MA, Jafari F, Rafiee S. Evaluation of efficacy of diode laser treatment on unwanted hair. Iranian J Dermatol 2006; 8(6): 74 - 5.


190.  Nilforoushzadeh MA, Jafari F, Ansarin N, et al. A comparative study on the efficacy of combination therapy with omeprazole and low dose systemic meglumine antimoniate (Glucantime) and the full dose systemic meglumine antimoniate in the treatment of cutaneous leishmaniasis. Iranian J Dermatol 2006; 8(6): 71 - 2


191.  Khamesipour A, Dowlati Y, Asilian A, et al. Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 2005; 23:3642-48.


192.  Firooz A, Bouzari N, Mojtahed F, et al. Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata. Journal Of The European Academy Of Dermatology And Venereology 2005;19:393-4.


193.  Eidsmo L, Nylen S, Khamesipour A, et al. The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous leishmaniasis. American Journal of Patholology 2005;166:1099-1108.


194.  Dowlati Y. Worldwilde skin diseases pattern. International  Journal of Dermatology 2005; 44:699.


195.  Bouzari N, Nouri K, Tabatabai H, Abbasi Z, Firooz A, Dowlati Y. The role of number of treatments in laser-assisted hair removal using a 755 nm alexandrite laser. Journal of Drugs in Dermatololoy 2005: 4:573-8.


196.  Nassiri-Kashani M, Gorouhi F, Behnia F, Nazemi MJ, Dowlati Y, Firooz A. Allergic contact dermatitis in Iran. Contact Dermatitis 2005 52:154-8.


197.  Firooz A, Sarhangnejad R, Davoudi SM, Nassiri-Kashani M. Acne and smoking: is there a relationship? BMC Dermatology. 2005;5(1):2.


198.  Firooz A, Khatami A, Khamesipour A, Nassiri-Kashani M, Behnia F, Nilforoushzadeh M, Pazoki-Toroudi H, Dowlati Y. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. Journal of Drugs in Dermatology. 2005;4:73-9.


199.  Nikzad A, Nobari H, Firooz A, Dowlati Y Macroglossia as a manifestation of post-kala-azar dermal leishmaniasis: a case report.. International Journal of Dermatology. 2005;44:129-31.


 


200.  Bouzari N, Tabatabai H, Abbasi Z, Firooz A, Dowlati Y. Hair removal using an 800-nm diode laser: comparison at different treatment intervals of 45, 60, and 90 days. International Journal of Dermatology. 2005;44:50-3.


 


201.  Firooz A, Firoozabadi MR, Ghazisaidi B, Dowlati Y. Concepts of patients with alopecia areata about their disease. BMC Dermatology. 2005;5(1):1.


202.  Firooz A, Sarhangnejad R. Parting thoughts on acne, skin aging, and smoking. Journal of Cosmetic Dermatology 2005; 4:49-51.


203.  Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishaniasis caused by L. major. European Journal of Dermatology. 2005;15:85-87.


204.  Khatami A, Firooz A, Ghorbani Z, et al. Co- occurrence of angiokeratoma and epidermal nevus: A case report. Iranian J Dermatol 2005; 8(5): suppl 1: 58


205.  Rasi A, Ansarin H, Khatami A. Uses of intravenous immunoglobulines. . Iranian J Dermatol 2005; 8(4): 67


206.  Bakhshizadeh M, Hedjazi SH, Jaffari F, et al. Effect of a nitric oxide releasing cream on cutaneous leishmaniasis in animal model. Iranian J Dermatol 2005; 8(4): 60


207.  Sadeghian G, Nilfroushzadeh MA, Motevali Emami M. A comparison between intra lesional hypertonic sodium chloride solution and meglumine antimoniate (Glucantime) injections in the treatment of cutaneous leishmaniasis. Iranian J Dermatol 2005; 8(4): 58.


208.  Davudi SM, Karimi Zarchi A, Ghafurimanesh S, et al. The frequency of skin allergens in patients with contact dermatitis. Iranian J Dermatol 2005; 8(3): 47.


209.  Firooz A, Bouzari N, Fallah N, et al. What patient with vitiligo believe about their condition, International Journal Of Dermatology. 2004;43:811-14.


210.  Bouzari N, Tabatabai H, Abbasi Z, et al. Laser hair removal: Comparison of long-pulsed Nd : YAG, long-pulsed alexandrite, and long-pulsed diode lasers. Dermatologic Surgery 2004;30:498-502.


211.  Mohebali M, Khamesipour A, Mobedi I, et al. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, IR Iran. Vaccine 2004;22:4097-100.


212.  Rasi A, Khatami A, Mirzazadeh Javaheri S. Macular amyloidosis: An assessment of prevalence, sex, and age. International Journal of Dermatology 2004; 43: 898-890.


213.  Rasi A, Khatami A. Autoimmune progesterone dermatitis. International Journal of Dermatology 2004; 43: 588-90.


214.  Farsi N, Firooz A, Rashighi Firoozabadi M. Pigmented Bowen's disease mimicking malignant melanoma: A case report. Iranian J Dermatol 2004; 8(1): 10.


215.  Sadeghian G, Iraji F, Nilfroushzadeh MA. Disseminated cutaneous leishmaniasis on lymphedema following radiotherapy:  A case report. Iranian J Dermatol 2004; 8: suppl 7.


216.  Nilforooshan Z, Asilian A, Nilforooshzadeh MA. Skin carcinoma arising in leishmania scar: report of four cases. Iranian J Dermatol 2004; 8: suppl 3.


217.  Firooz A, Khatami A, Nassiri-Kashani M, et al. A comparison between the efficacy of intralesional injection of 2% zinc sulfate solution with Glucantime in the treatment of acute Old World cutaneous leishmaniasis: a randomized, double- blind, controlled clinical trial. Iranian J Dermatol 2004; 7(4): 28.


218.  Nilforooshzadeh MA, Jaffari F,Malekafzali B. Efficacy of combined triple therapy (paramomycin ointment, cryotherapy  and intralesional Glucantime) for the treatment of acute cutaneous leishmaniasis. Iranian J Dermatol 2004; 3(7): 18.


219.  Sadeghian G, Nilforooshzadeh MA, Ansarin N. Palpebral leishmaniasis with trichiasis: a case report. Iranian J Dermatol 2004; 7(2): 16.


220.  Firooz A, Khatami A. A reveiew on evidence based medicine. Iranian J Dermatol 2004; 7(2): 15.


221.  Nilforooshzadeh MA, Late Jalayer T, Ataiee B, et al. Efficacy of integration methods in the control of cutaneous leishmaniasis in Imamzadeh Agha Ali Abbas in Natanz in Isfahan in 1996-1998. Iranian J Dermatol 2004; 7(2): 11.


222.  Nilforoushzadeh MA, Raiszadeh MR,Jafari F, etal. Therapeutic effects of cryotherapy, paramomycin, and local glucantim in lupoid leishmaniasis and chronic leishmaniasis. Pajouhandeh 2004; 8(36): 6


223.  Sadeghian G, Hejazi SH, Nilfroushzadeh MA. Identification of leishmania species from atypical lesions using monoclonal antibodies. The Journal of Faculty of Medicine  2004; 62(5): 54.


224.  Mahmoodi M, Khamesipour A, Dowlati Y, et al. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.  Clinical And Experimental Immunology 2003;134:303-8.


225.  Asilian A, Jayaler T, Nilforooshzadeh M,Modabber F, et al. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bulletin Of The World Health Organization 2003; 81(5):353-59.


226.  Firooz A, Khamesipour A, Dowlati Y. Itraconazole pulse therapy improves the quality of life of patients with toenail onychomycosis. Journal of Dermatological Treatment 2003; 14:95-98.


227.  Ahmadi Mousavi M, Damghani M, Haghdoust A, Khamesipour A. Opium and risk of laryngeal cancer. Laryngoscope 2003; 113:1939-43.


228.  Motevali Emami M, Nilforooshzadeh MA, Yazdi M. Evaluation of three drug formulations (linden, premethrin, copex) in the treatment of head lice infestation. Iranian J Dermatol 2003; 7(1): 4.


229.  Farnaghi F, Seirafi H, Firooz A, Jamshidi F. Prevalence and risk factors of joint diseases in patients with psoriasis referred to Razi Skin Hospital in Tehran. Iranian J Dermatol 2003; 7(1): 2.


230.  Nilforooshzadeh MA,  Reissizadeh MR, Jaffari F. topical trichloro acetic acid compaired with intralesional Glucantime injection in the treatment of acute wet cutaneous leishmaniasis. An open clinical trial. Iranian J Dermatol 2003; 2(5): 6.


231.  Alimohammadian MH, Khamesipour A, Darabi H, Firooz A, Malekzadeh S, Bahonar A, Dowlati Y, Modabber F. The role of BCG  in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis. Vaccine 2002; 21:174-80.


 


232.  Abbot NC, Beck J, Feval F, Weiss F, Mobayen MH, Ghazi-Saidi K, Dowlati Y, Velayati AA, Stanford JL. Randomized clinical trial: Immunotherapy with Mycobacterium vaccae and peripheral blood flow in long treated leprosy patient, a randomized, placebo controlled trial. European Vascular Endovascular Surgery 2002; 24:202-208.


233.  Sharifi I, Fekri A, Aflatonian MR, Madjdzade SR, Ahmadi-Mousavi MR, Khamesipour A, Nadim A. Tuberculin skin tests of 11, 116 primary school children in the Bam city, southern Iran. Hamdard Medicus 2002, 1:27-31.


234.  233.   Chams-Davatchi C, Nonahalazar R, Daneshpazhooh M, Valikhani M, Hallaji Z, Barzegari M, Firouz A. R, Zakeri M. Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris. Annales de Dermatologie et de   Venereologie 2002;129:23-25.


235.  Abrishami M, Soheilian M, Frahi A, Dowlati Y. Successful of ocular leishmaniasis. European Journal of Dermatology 2002;12: 88-89.


236.  Firooz A, Nassiri-Kashani M, Ghazisaidi M, Ghasemi M. Radiosurgical treatment of rhnophyma: a case report. In: Proceedings 11th EADV Congress Prague 2002. Bologna: M.N.L. Scientific Publishing & Communication, 2002:15-17.


237.  Nassiri-Kashani M, Firooz A. Patch test and its  practical points. Iranian J Dermatol 2002; 1(6): 6.


238.  Nilforooshzadeh MA, Fakhri Shooshtari MM, Djafari F. Cutaneous and mucosal lesions in 117 renal transplantation patients referred to Noor and Ali Asghar Hospitals in Isfahan in June and July 1997. Iranian J Dermatol 2002; 5(4): 2.


 


239.  Mortazavi H, Khamesipour A, Hallaji Z, etal. Interferon-γ production and leishmanin skin test in non- healing cutaneous leishmaniasis compared with healed individuals. Iranian J Dermatol 2002; 5 (4): 1.


240.  Mojtahed F ,Karimzadegan Nia M.What is your diagnosis. Iranian J Dermatol 2002; 5(3): 50-3.


241.  Sadeghian G, Nilforooshzadeh MA. Nodular fibrosis in non-filarial elephantiasis: a case report. Iranian J Dermatol 2002; 5(2): 7.


242.  Firooz A, Firoozabadi Mr, Dowlati Y. Rosacea fulminans (pyoderma faciale): successful treatment of a 3-year-old girl with oral isotretinoin. International Journal of Dermatology 2001;40: 191-209.


243.  Habibi G R, Khamesipour A, Mc Master WR, Mahboudi F. Cytokine gene expression in healing and non-healing cases of cutaneous leishmaniasis in response to In vitro stimulation with recombinant gp63 using semi- quantitative RT-PCR. Scandinavian Journal of Immunology. 2001;54:414-20.


 


244.  Mortazavi H. Dowlati Y. A brief history of dermatology in Iran. Archives of Dermatology 2001;137: 936-37.


 


245.  Lotfi M, Firooz A, Nosrati A, Tabatabai H, Dowlati Y. Linear atrophy, telangiectases, and soft nodules along the lines of Blaschko with skeletal abnormalities. Archives of Dermatology 2001;137:1095- 1100.


246.  Salek Moghaddam AR, Ostad-Ashtiani F, Firooz A, et al. Immunophenotypic evaluation of peripheral blood lymphocyte subgroups in patients with allergic contact dermatitis compared with other dermatitis and normal individuals. Journal  of Iran UMS 2001; 7(22); 339.


247.  Heydari Seraj M, Naderi N, Naderi EA, Seyf Naraghi M. psychological assessment of women with acne vulgaris. Iranian J Dermatol 2001; 4(3): 5.


248.  Bouzari N, Firooz A, Tabatabai H, Dowlati Y. Minoxidil in combination with tretinoin vs minoxidil in the treatment of male androgenetic alopecia: a randomized, double blind, parallel clinical trial. Iranian J Dermatol 2001; 4(3): 4.


249.  Firooz A, Rashighi firoozabadi M, Ghazisaidi B, Dowlati Y. Illness perception and quality of life in patient with alopecia areata. Iranian J Dermatol 2001; 4(3): 2.


 


250.  Tabatabai H, Boozari N. Peripheral nerve involvement without skin lesions in leprosy. No Tabatabai H, Heydari Seraj M. Dapson and its uses in dermatology. Iranian J Dermatol 2000; 4(1): 6.


251.  Shamsaddini S, Nassiri-Kashani M, Sharifi I, Khaje Karimoddini M, Pour Lashkari M. Iranian J Dermatol 2000; 4(1): 3.


252.  Hejazi H, Nasirfar P, Jamali S, et al. Identification of leishmania species using monoclonal antibodies in Isfahan. Iranian J Dermatol 2000; 4(1): 1.


253.  Gholami A, Khamesipour A, Momeni A, et al. Treatment of cutaneous leishmaniasis with 5% garlic cream: a randomized double blind study. Iranian J Dermatol 2000; 3(3): 1.


254.  Firooz A, Dowlati Y. IgE level and validation of the diagnostic criteria for atopic dermatitis. Archives of Dermatology 1999;135:1550-51.


255.  Firooz A, Komeili A, Dowlati Y. Eruptive melanocytic nevi and cherry angiomas secondary to exposure to sulfur mustard gas. Journal Of The American Academy Of Dermatology 1999;40: 646-647.


256.  Momeni A, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Labaf- Ghasemi R, Dowlati Y, Sharifi I, et al. A randomised,  double-blind, controlled trial of a killed L-major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine 1999;17: 466-472.


257.  Firooz A, Davoudi SM, Farahmand A, et al. Validation of the diagnostic criteria for atopic dermatitis. Archives Of Dermatology 1999; 135: 514-516.


258.  Tabatabai H. Pure neural leprosy: a case report. Iranian J Dermatol 1999; 3(1): 10


259.  Nosrati A, Nassiri-Kashani M. Malignant skin lesions in transplant recipients. Iranian J Dermatol 1999; 3(1): 8


260.  Momeni A, Khamesipour A,Bagherzadeh A, Aminjavaheri M. Comparison of different antigens for leishmanin skin test in patients with cutaneous leishmaniasis. Iranian J Dermatol 1999; 3(1): 6


261.  Riahi Dehkordi, Firooz A. Significant drug interactions in dermatology. Iranian J Dermatol 1999; 2(4): 6


262.  Firooz A. Guidelines for the use of systemic  drugs in the treatment of skin diseases. Iranian J Dermatol 1999; 2(3): 9


263.  Ebne Ahmadi E, Sooudi P, Dowlati Y. The impact of  stress on the expression and severity of psoriasis. Iranian J Dermatol 1999; 2(3): 4


264.  Mandegarfard M, dowlati Y. Diffuse plane xantomatosis: a case report. Iranian J Dermatol 1999; 2(2): 8


265.  Firooz A, Dowlati Y. Diagnostic guidelines for management of atopic dermatitis. Journal of Medical Council of I.R.I. 1999; 17(1): 52-7.


266.  Ansarin H, Firooz A, Azimi M, Ebn-Ahmadi E, Dowlati Y. Prevalence of atopic dermatitis in children in Iran. The Gulf Journal of Dermatology  1998;5: 26-27.


267.  Sharifi I, Fekri A, Aflatonian M, Khamesipour A, Nadim A, Ahmadi Mousavi M, Momeni A, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet 1998;351:1540-43.


 


268.  Sharifi I, Fekri AR, Aflatonian MR, Nadim A, Nikian Y and Khamesipour A. Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-5. Bulletin of the World Health Organization, 1998, 76: 289-93.


269.  Heshami-Fesharki R, Ale- Agha S, Khamesipour A, et al. Production of inactivated wet rural leishmania vaccine against Leishmania major. Iranian Journal of Medical Science 1998; 23: 74-80.


270.  Dowlati B, Firooz A, Khamesipour A, Lotfi M, et al. Insulin quantification in patients with seborrheic dermatitis. Archives of  Dermatology 1998; 134: 1043-45.


271.  Miramin Mohammadi A, Firooz A. A case of toenail onychomycosis with Scopulariopsis brevicalis. Iranian J Dermatol 1998; 2(1): 6


272.  Momeni A, Asilian A, Meghdadi M, et al. Anticonvulsant hypersensitivity syndrome. Iranian J Dermatol 1998; 2(1): 5


273.  Tabatabai H, Dowlati Y. Guideline of care for vitiligo. Iranian J Dermatol 1998; 1: 10


274.  Sepehri P, Firooz A, Dowlati Y. A pitfall in dermatopathology: case report. Iranian J Dermatol 1998; 1: 8


275.  Tabatabai H, Haji-Abbas Z. Rediscovering thalidomide: clinical review. Iranian J Dermatol 1998; 1: 2


276.  Mobini N, Yunis Ej, Alper C, Firooz A, et al. Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: Possible common central Asian ancestral origin. Human Immunology, 1997;57: 62-67.


277.  Dowlati B, Firooz A, Dowlati Y. Granuloma faciale: successful treatment of nine cases with a combination of cryotherapy and intralesional corticosteroid injection. International Journal Of Dermatology 1997;36 : 548-51.


278.  Dowlati Y, Firooz A. Leishmaniasis.  Journal of the American Academy of Dermatology 1997;37:139-40.


279.  Sharifi I, Ardehali S, Khamesipour A, Dowlati Y, et al. Identification and characterization of Leishmania isolates in school children in Bam, southeastern Iran. Iranian Journal of Medical Science 1997;22: 82-88.


280.  Mirshams Shahshahani M, Firooz A, Naraghi Z, Dowlati Y. Malignant atrophic papulosis (Degos Disease): report of a rapidly fatal case. The Gulf Journal of Dermatology and Venereology 1997;4: 41-42.


281.  Hejazi SH, Khamesipour A, Alimohammadian MH, Allameh A, Dowlati Y. Brief Communications. A comparison between the protein profile of intact and two preparations of killed Leishmania major by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Medical Journal  of Islamic Republic of Iran 1997; 11:177-80.


282.  Rafati-Seyedi-Yazdi S, Couty-Jouve, Alimohammadian M, Dowlati Y. Evaluation of cellular immune responses to amastigote soluble Leishmania major antigens in recovered cases of cutaneous leishmaniasis. Medical  Journal of Islamic Republic of Iran. 1997;11: 33-38.


283.  Dowlati Y. Treatment of cutaneous  leishmaniasis (old world). Clinics  in Dermatology 1996; 14: 513-517.


284.  Firooz A, Mobini N, Bahar K, Shams S, Ahmed AR, Dowlati Y. Antigenic specificities of Iranian patients with pemphigus vulgaris. Iranian Journal of Medical Sciences. 1996;21:47-49.


285.  Firooz A, Mobini N, Bahar k, Shams S, Ahmed RA, Dowlati Y. Presence of anti desmoglein 3 auto antibodies in healthy relatives of Iranian patients with pemphigus vulgaris. The Gulf Journal of Dermatology and Venereology 1996;3: 18-20.


286.  Dowlati Y. Cutaneous leishmaniasis: Clinical aspects. Clinics In Dermatology 1996;14: 425-31.


287.  Bahar K, Dowlati Y, Shidani B, et al. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers. Clinics In Dermatology 1996;14: 489-95.


288.  Dowlati Y, Ehsasi S, Shidani B, et al. Stepwise safety trial of a killed Leishmania vaccine in Iran, Clinics In Dermatology 1996;14:497-502.


289.  Ghorbani Z, Dowlati Y, Mehregan AH. Amelanotic spitzoid melanoma in the burn scar of a child. Pediatric Dermatology 1996;3: 285-87.


290.  Firooz A, Tehranchi-Nia Z, Ahmed AR. Benefits and risks of intralesional corticosteroid injection in treatment of dermatological diseases. Clinical and Experimental Dermatology 1995; 20: 363-70.


291.  Javadi MA, Mirdehghan SA, Bagheri M, Dowlati Y, Sajjadi H. Richner –Hanhart syndrome: (Tyrosinemia Type II ) report of 2 cases in family. Middle East Journal of Ophthalmology 1995;3:197-202.


292.  Firooz A, Mazhar A, Razzaque Ahmed A. Prevalence of autoimmune disease in the family of patients with pemphigus vulgaris. Journal of American Academy of dermatology. 1994; 31: 3(pt1), 434-437


293.  Dowlati A, Dowlati Y, Hermanns-Le T, Pierard GE. Clinical, microscopic and ultrastructural alterations due to mustard gas poisoning. Journal of the European Academy of Dermatology & Venereology 1992;1:199-204.


294.  Asilian A, Khamesipour A, Modabber F. Leishmaniases. Postgraduare Doctor Middle East 21(5) 174-181.


295. Azin Ayatollahi, Hamed Hosseini, Jaleh Gholami, Babak Mirminachi, FaridHossein Firooz & Alireza Firooz , Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature

 

296. Azin Ayatollahi Center for Research and Training in Skin diseases and Leprosy, Tehran University of Medical Science, Tehran, Iran; , Hamed Hosseini, Jaleh Gholami, Babak Mirminachi, FaridHossein Firooz & Alireza Firooz, Platelet rich plasma for treatment of non-scarring hair loss: systematic review of literature

 

297. Ali Rajabi-Estarabadi, Hournaz Hasanzadeh, Arash Taheri, Steven R. Feldman & Alireza Firooz , The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis

 

298. Ali Rajabi-Estarabadi Center for Research & Training in Skin Diseases & Leprosy, Tehran, Iran; , Hournaz Hasanzadeh, Arash Taheri, Steven R. Feldman & Alireza Firooz , The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis

ISD Mentorship Program

 
 

ccd2018

دانشگاه نسل سوم، اشتغال و تولید دانش بنیان

 

Derma_Mag_Side

 
 
 

تالار همایش دکتر دولتی